Combination therapy for combined dyslipidemia
- 1 November 2002
- journal article
- review article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 90 (10) , 21-29
- https://doi.org/10.1016/s0002-9149(02)02968-5
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: effect of 5 hydroxymethylglutaryl coenzyme A reductase inhibitors on non-high-density lipoprotein cholesterol levelsThe American Journal of Cardiology, 2001
- Gemfibrozil for the Secondary Prevention of Coronary Heart Disease in Men with Low Levels of High-Density Lipoprotein CholesterolNew England Journal of Medicine, 1999
- The antiatherogenic role of high-density lipoprotein cholesterolThe American Journal of Cardiology, 1998
- Low-density lipoproteins and risk for coronary artery diseaseThe American Journal of Cardiology, 1998
- Cholesterol Reduction Yields Clinical BenefitCirculation, 1998
- Hypertriglyceridemia, Atherogenic Dyslipidemia, and the Metabolic SyndromeThe American Journal of Cardiology, 1998
- Secondary prevention of heart disease amongst patients with lipid abnormalities: practice and trends in the United StatesJournal of Internal Medicine, 1997
- Plasma triglyceride and coronary heart disease.Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1991
- High-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies.Circulation, 1989
- Incidence of Coronary Heart Disease and Lipoprotein Cholesterol LevelsJAMA, 1986